Patrick Hearing Selected Research

Neoplasms (Cancer)

3/2023	B cell-intrinsic STAT3-mediated support of latency and interferon suppression during murine gammaherpesvirus 68 infection revealed through an in vivo competition model.
1/2022	Cytokine pathway variants modulate platelet production: IFNA16 is a thrombocytosis susceptibility locus in humans.
10/2019	An Interaction with PARP-1 and Inhibition of Parylation Contribute to Attenuation of DNA Damage Signaling by the Adenovirus E4orf4 Protein.
1/2019	Biphasic Functional Interaction between the Adenovirus E4orf4 Protein and DNA-PK.
8/2011	Unnatural amino acid incorporation onto adenoviral (Ad) coat proteins facilitates chemoselective modification and retargeting of Ad type 5 vectors.
10/2010	Chemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick Hearing Research Topics

Disease

23	Infections 03/2023 - 05/2005
7	Virus Diseases (Viral Diseases) 01/2016 - 05/2003
6	Neoplasms (Cancer) 03/2023 - 10/2010
3	Adenoviridae Infections (Adenovirus Infections) 01/2016 - 05/2003
2	Inflammation (Inflammations) 05/2024 - 01/2016
2	Thrombocytosis (Thrombocythemia) 01/2022 - 12/2008
2	Persistent Infection 01/2022 - 01/2020
2	Leukemia 01/2020 - 04/2007
2	Hemophilia A (Haemophilia) 12/2008 - 08/2004
1	Colitis 05/2024
1	Ulcerative Colitis 05/2024
1	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2023
1	Retinoblastoma (Glioblastoma, Retinal) 01/2022
1	COVID-19 12/2021
1	RNA Virus Infections 12/2021
1	Bites and Stings (Sting) 12/2021
1	Zika Virus Infection 01/2020
1	Plague (Bubonic Plague) 09/2016
1	Breast Neoplasms (Breast Cancer) 08/2011
1	Stroke (Strokes) 06/2011
1	Coinfection 11/2002

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
8	InterferonsIBA 03/2023 - 05/2007
5	Antiviral Agents (Antivirals)IBA 12/2021 - 01/2016
5	Viral DNAIBA 10/2019 - 05/2005
4	A-Form DNA (A-DNA)IBA 12/2021 - 05/2011
3	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 11/2002
2	Viral Core ProteinsIBA 06/2017 - 05/2011
2	Viral ProteinsIBA 01/2016 - 01/2011
2	adenovirus L4-22K proteinIBA 07/2013 - 10/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 08/2011 - 10/2010
2	Factor VIII (Coagulation Factor VIII)IBA 12/2008 - 08/2004
1	Tn antigenIBA 05/2024
1	Interleukin-22 (IL-22)IBA 05/2024
1	MucinsIBA 05/2024
1	Polysaccharides (Glycans)IBA 05/2024
1	Dextran SulfateIBA 05/2024
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2023
1	Histone Deacetylase InhibitorsIBA 01/2022
1	NucleotidesIBA 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2022
1	CytokinesIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 12/2021
1	Interferon LambdaIBA 12/2021
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2019
1	HeterochromatinIBA 01/2019
1	DNA-Activated Protein KinaseIBA 01/2019
1	Type III Secretion SystemsIBA 09/2016
1	InflammasomesIBA 09/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	ChromatinIBA 01/2016
1	Trans-Activators (Trans-Acting Factor)IBA 01/2016
1	HMGB1 Protein (HMG1)IBA 01/2016
1	Tyrosine (L-Tyrosine)FDA Link 08/2011
1	Protein Tyrosine PhosphatasesIBA 08/2011
1	Adenosine Triphosphatases (ATPase)IBA 06/2011
1	Capsid Proteins (Capsid Protein)IBA 01/2011
1	Platelet Factor 4IBA 12/2008
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2007
1	Arginine (L-Arginine)FDA Link 02/2005
1	AcetyltransferasesIBA 05/2003
1	Adenovirus Early ProteinsIBA 05/2003